News
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'd ...
19h
Barchart on MSNCardinal Health Earnings Preview: What to ExpectCardinal Health is preparing to announce its second-quarter results next month, and analysts are anticipating an earnings ...
The rapper, whose legal name is John-Michael Gibson, was convicted of charges including rape and violating the RICO Act for ...
Prosecutors say their investigation uncovered that Gibson’s income from sex trafficking far exceeded any earnings from his ...
9d
Zacks.com on MSNWill Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Results from the Phase III CAHtalyst show that patients treated with Crenessity for classic congenital adrenal hyperplasia ...
7d
MedPage Today on MSNAdults, Kids With Classic CAH May Have Better Metabolic Profiles With CrinecerfontSAN FRANCISCO -- Crinecerfont (Crenessity) may help improve metabolic profiles of adults and children with classic congenital ...
OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025
OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including congenital adrenal ...
CAH Quantitative Stock Analysis June 28, 2025 — 03:06 pm EDT Written by John Reese for Validea -> Below is Validea's guru fundamental report for CARDINAL HEALTH INC (CAH).
5d
Zacks.com on MSNTMO to Report Q2 Earnings: Analytical Instruments Segment in FocusThe consensus mark for earnings is pegged at $5.22 per share, indicating a 2.8% decline from the year-ago quarter’s reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results